Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

Bullboard Posts

Comment by your_solution1on Nov 17, 2012 3:12pm

208 Views

Post# 20613949

RE: Great Find, there is alot to be taken

I watch NPC since years and I know what they working on is simply said GREAT. Canaccord's opinion means nothing to me; their suggestion doesn't sound professional, at least not to me. I know how difficult it is to get FDA approval; Allon is on the right track, just let's expect the best. It could become a once of a lifetime investment.

Everything in life has risks of failure, but Allon has the ability to succeed. Cheers!

Bullboard Posts

How one company is disrupting PoC testing